MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lipid metabolism"

  • 2025 International Congress

    Metabolomics Profiling in Egyptian Patients with Alzheimer’s and Parkinson’s Diseases

    S. Abdelaziz, A. Helmy, E. Hamid, M. Salama, A. Shalash (Cairo, Egypt)

    Objective: To identify differential serum metabolites found in AD and PD patients and their correlations to clinical presentation in Egyptian patients. Background: There is a…
  • 2025 International Congress

    Plasma Lipids as Potential Biomarkers for Progression of Sleep Disturbances in Parkinson’s Disease

    M. Mchorney, R. Rajhmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: Determine if plasma lipid levels can serve as a surrogate biomarker of future onset of RBD symptoms or nighttime sleep burden in patients with…
  • 2025 International Congress

    Sex specific role of dyslipidemia and statin use in Parkinson’s disease pathogenesis

    K. Tsutsumi, E. Shah, S. Isfahani (Orange, USA)

    Objective: Our aim was to characterize the role of dyslipidemia and statin use in Parkinson’s disease (PD) development, specifically with respect to differences in significance…
  • 2025 International Congress

    Fatty Acid Metabolic Reprogramming Regulates Glial-Epithelial Axis via Nur77 Palmitoylation in Intestinal Dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, Z. Lu, X. Luo, F. Yu, W. Bi (Guangzhou, China)

    Objective: This study aims to elucidate the regulatory role of stearoyl-CoA desaturase 1 (SCD1) in Parkinson’s disease (PD)-associated intestinal dysfunction, focusing on its mechanism in…
  • 2025 International Congress

    Genetic Correlations Between Parkinson’s Disease and Circulating Metabolites

    M. Tan, T. Ascencio, S. Rodriguez-Quiroga, J. Largo González, S. Peña Martinez, L. Hernandez Delgado, A. Noyce (San Salvador, El Salvador)

    Objective: To use genome-wide association studies (GWASs) to identify genetic correlations between Parkinson’s disease (PD) and circulating metabolites. Background: Metabolomics is the study of small…
  • 2025 International Congress

    Rare Variant Analysis of Sphingolipid-related Genes in Large Chinese Parkinson’ s Disease Cohorts

    JB. Liu, YW. Zhao, XM. Guo, Q. Yin, R. Gao, BS. Tang, JF. Guo (Changsha, China)

    Objective: This study investigated the link between rare variants in sphingolipid-related genes and Parkinson’s disease (PD) in a Chinese mainland population. Background: Recently, growing evidence…
  • 2025 International Congress

    Association of high-density lipoprotein cholesterol and related inflammatory index with neurodegeneration in drug-naïve dementia with Lewy bodies

    T. Umehara, M. Mimori, M. Ozawa, T. Shiraishi, T. Kitagawa, M. Ikeda, H. Matsuno, S. Omoto, R. Sengoku, H. Murakami, Y. Iguchi (Tokyo, Japan)

    Objective: We aimed to clarify the association of serum cholesterol levels and related inflammatory index with the degeneration of nigrostriatal dopaminergic neurons and clinical symptoms…
  • 2025 International Congress

    Oligodendrocyte-specific mRNA therapy with lipid nanoparticles

    M. Sawamura, K. Tachikawa, R. Hikawa, H. Yamakado, R. Takahashi, S. Matsuzawa (San Diego, USA)

    Objective: To develop lipid nanoparticles with high efficiency and specificity to introduce mRNA into oligodendrocytes. To denmonstrate the potential therapy of Krabbe disease as one…
  • 2025 International Congress

    Using Zebrafish Model to Investigate Complex Hereditary Spastic Paraplegia Caused by EPT1 Variants

    S. Wang, S. Banka, M. Lowe, A. Nicolaou (Manchester, United Kingdom)

    Objective: To generate disease-representative zebrafish models using CRISPR-Cas9 technique.To characterise the zebrafish models by performing phenotypic characterization, neurobiological experiments, lipidomic and RNASeq studies.To test targeted…
  • 2025 International Congress

    Efficacy of adhering to a Ketogenic Diet in Parkinson’s Disease: a Systematic Review and Meta-Analysis

    G. Guindani Maia, V. Ritt Xavier, V. Serafim, M. Neto, L. Nardi Motta, V. Müller, I. Alicia Fink, AC. Sgarioni Viapiana, MF. Peruci Felippe, L. Bedatti Koehler, C. Rieder (Porto Alegre, Brazil)

    Objective: We aimed to analyse the efficacy of Ketogenic Diet (KD) in metabolic and motor characteristics of patients with Parkinson's Disease (PD). Background: Many studies…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley